Trials / Unknown
UnknownNCT05421780
Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome
Impact of Brewer's Spent Grain (BSG) and Bio-transformed BSG Biscuits on Post-prandial Glycaemic Controlling Effects in Singapore Adults With Metabolic Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- National University of Singapore · Academic / Other
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS. The investigators hypothesized that consumption of BSG and bio-transformed BSG containing biscuit will improve glycaemic control.
Detailed description
This is a double-blind, randomised, crossover experiment. During the 3-week, 19 subjects will participate in a 3 meal tolerance test (MTT). During each MTT session, all subjects are required to consume 90 g biscuits (either control, autoclaved BSG or bio-transformed BSG biscuits) and monitored over a period of 240 minutes. All three types of biscuits will be consumed at a randomised sequence during this 3-week period. Post-prandial blood glucose, insulin, lipid and amino acid responses, breath analysis, body composition, blood pressure, appetite assessment, and any other glycaemic biomarkers will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | autoclaved BSG-containing biscuits | Consumption of autoclaved BSG-containing biscuits as breakfast. |
| DIETARY_SUPPLEMENT | bio-transformed BSG-containing biscuits | Consumption of bio-transformed BSG-containing biscuits as breakfast. |
| DIETARY_SUPPLEMENT | control biscuits | Consumption of plain biscuits as breakfast. |
Timeline
- Start date
- 2022-06-29
- Primary completion
- 2022-12-13
- Completion
- 2024-07-01
- First posted
- 2022-06-16
- Last updated
- 2023-11-09
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT05421780. Inclusion in this directory is not an endorsement.